| P50 | author | Cynthia Marie-Claire | Q57698362 |
| | Frank Bellivier | Q56479996 |
| | Florence Vorspan | Q42907302 |
| P2093 | author name string | Jean-Pierre Lépine | |
| | Vanessa Bloch | |
| | Clément Jourdaine | |
| P2860 | cites work | ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment | Q57550258 |
| | Epigenetic mechanisms of drug addiction | Q22251252 |
| | Buprenorphine: a unique drug with complex pharmacology | Q24642980 |
| | MicroRNAs as biomarkers for CNS disease | Q27013998 |
| | Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats | Q27304542 |
| | Upregulation of SOCS-3 and PIAS-3 Impairs IL-12-Mediated Interferon-Gamma Response in CD56+ T Cells in HCV-Infected Heroin Users | Q27491026 |
| | Hat2p recognizes the histone H3 tail to specify the acetylation of the newly synthesized H3/H4 heterodimer by the Hat1p/Hat2p complex | Q27683819 |
| | Chromatin modifications and their function | Q27861067 |
| | MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions | Q28080201 |
| | Genome-Wide Association of Heroin Dependence in Han Chinese | Q28554877 |
| | Functions of DNA methylation: islands, start sites, gene bodies and beyond | Q29547260 |
| | Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 |
| | Transgenerational epigenetic inheritance in mammals: how good is the evidence? | Q30251679 |
| | Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments | Q33238415 |
| | Chromatin-modifying and -remodeling complexes | Q33632339 |
| | Is human blood a good surrogate for brain tissue in transcriptional studies? | Q33723516 |
| | Mechanisms of epigenetic memory | Q33810523 |
| | Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response | Q33903933 |
| | Pharmacotherapy in the treatment of addiction: methadone | Q33914167 |
| | Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels | Q34069882 |
| | MicroRNAs: master regulators of ethanol abuse and toxicity? | Q34078032 |
| | Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction | Q34118780 |
| | The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample | Q34119478 |
| | Up-regulation of microRNAs in brain of human alcoholics | Q34190564 |
| | Proton-coupled hole hopping in nucleosomal and free DNA initiated by site-specific hole injection | Q34242651 |
| | Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers | Q34473458 |
| | Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder | Q34571298 |
| | Methadone induces CAD degradation and AIF-mediated necrotic-like cell death in neuroblastoma cells. | Q34625707 |
| | Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts | Q34656790 |
| | Regulation of nonphosphorylated and phosphorylated forms of neurofilament proteins in the prefrontal cortex of human opioid addicts | Q44332350 |
| | ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals | Q44333294 |
| | Demethylation regulation of BDNF gene expression in dorsal root ganglion neurons is implicated in opioid-induced pain hypersensitivity in rats | Q44335797 |
| | Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain | Q44337324 |
| | Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment | Q44339701 |
| | Pharmacoepigenetics of the role of DNA methylation in μ-opioid receptor expression in different human brain regions | Q44340444 |
| | Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts | Q44344535 |
| | Alteration of lymphocyte opioid receptors in methadone maintenance subjects | Q44344561 |
| | Regulation of immunolabelled mu-opioid receptors and protein kinase C-alpha and zeta isoforms in the frontal cortex of human opiate addicts | Q44345799 |
| | β-Arrestin2 influences the response to methadone in opioid-dependent patients. | Q44346717 |
| | Effect of chronic heroin and cocaine administration on global DNA methylation in brain and liver. | Q44521498 |
| | Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample | Q44588941 |
| | Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice | Q44719752 |
| | Histone H3 phosphoacetylation is critical for heroin-induced place preference | Q45249049 |
| | Expression levels of the BDNF gene and histone modifications around its promoters in the ventral tegmental area and locus ceruleus of rats during forced abstinence from morphine | Q45699084 |
| | Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo. | Q45960896 |
| | Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal | Q46220739 |
| | Morphine causes a delayed increase in glutamate receptor functioning in the nucleus accumbens core | Q46390279 |
| | Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving | Q46493884 |
| | Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. | Q46574866 |
| | Family and environmental factors of drug addiction among young recruits | Q46712211 |
| | CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence | Q46825133 |
| | Childhood trauma are not associated with the intensity of transient cocaine induced psychotic symptoms | Q47678999 |
| | Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment | Q48065707 |
| | The influence of heroin abuse on glutathione-dependent enzymes in human brain | Q48089749 |
| | Morphine withdrawal produces ERK-dependent and ERK-independent epigenetic marks in neurons of the nucleus accumbens and lateral septum. | Q48195741 |
| | Okadaic acid blocks the effects of 5-aza-2-deoxycytidine on consolidation, acquisition and retrieval of morphine-induced place preference in rats | Q48594952 |
| | Evaluating the comparability of gene expression in blood and brain | Q48623627 |
| | Increased serum brain-derived neurotrophic factor levels during opiate withdrawal | Q48785111 |
| | Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. | Q50662543 |
| | Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties. | Q50672428 |
| | CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. | Q50797242 |
| | Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine. | Q51035649 |
| | Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. | Q51761037 |
| | Screening for illicit heroin use in patients in a heroin-assisted treatment program. | Q52289783 |
| | Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment. | Q52290614 |
| | Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. | Q52298317 |
| | Temperament and character modify risk of drug addiction and influence choice of drugs. | Q52301332 |
| | Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts. | Q52308504 |
| | Methylation analysis of circadian clock gene promoters in forensic autopsy specimens. | Q54372154 |
| | Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. | Q54611266 |
| | Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes | Q34756351 |
| | Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol | Q34836140 |
| | Prefrontal cortex plasticity mechanisms in drug seeking and relapse | Q35014177 |
| | Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment | Q35087543 |
| | Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study. | Q35147971 |
| | MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. | Q35171243 |
| | Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring | Q35269497 |
| | Differential activation of G-proteins by mu-opioid receptor agonists | Q35545366 |
| | Gene expression in the addicted brain | Q35592193 |
| | Epigenetic modulation of brain gene networks for cocaine and alcohol abuse. | Q35626140 |
| | Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs | Q35650384 |
| | Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity | Q35684822 |
| | Alterations in serum microRNA in humans with alcohol use disorders impact cell proliferation and cell death pathways and predict structural and functional changes in brain | Q35765140 |
| | Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects | Q35826959 |
| | Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments | Q36056325 |
| | Morphine-induced changes of gene expression in the brain | Q36105247 |
| | Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line | Q36211219 |
| | Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation | Q36216466 |
| | Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood | Q36245292 |
| | Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages | Q36245718 |
| | Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior | Q36335668 |
| | Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure | Q36357339 |
| | Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression | Q36393054 |
| | Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications | Q36437440 |
| | ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics | Q36441533 |
| | Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review | Q36454768 |
| | Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation | Q36554599 |
| | Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence | Q36587882 |
| | Distinctive Roles of 5-aza-2'-deoxycytidine in Anterior Agranular Insular and Basolateral Amygdala in Reconsolidation of Aversive Memory Associated with Morphine in Rats | Q36685797 |
| | Alcohol Use During Pregnancy is Associated with Specific Alterations in MicroRNA Levels in Maternal Serum | Q36780087 |
| | Identification of long noncoding RNAs dysregulated in the midbrain of human cocaine abusers | Q36795258 |
| | Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels | Q36798293 |
| | Global DNA promoter methylation in frontal cortex of alcoholics and controls. | Q36842272 |
| | MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-κB signaling and caused opioid-induced immunosuppression in human monocytes | Q36915560 |
| | ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence | Q37008505 |
| | Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts | Q37084865 |
| | Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England | Q37106422 |
| | Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment | Q37160674 |
| | Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction | Q37401604 |
| | The implications of medication development in the treatment of substance use disorders in developing countries. | Q37433717 |
| | Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial | Q37625536 |
| | Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways | Q37711041 |
| | Let-7 microRNAs and Opioid Tolerance | Q38022011 |
| | An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure | Q38138785 |
| | What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries | Q38151439 |
| | Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis | Q38184547 |
| | Chromatin dynamics: interplay between remodeling enzymes and histone modifications | Q38192410 |
| | Novel types and sites of histone modifications emerge as players in the transcriptional regulation contest | Q38249060 |
| | Principles of miRNA-mRNA interactions: beyond sequence complementarity | Q38513793 |
| | Epigenetic Mechanisms of Psychostimulant-Induced Addiction | Q38526694 |
| | Lateral Thinking: How Histone Modifications Regulate Gene Expression | Q38679432 |
| | The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research | Q38848288 |
| | DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML | Q38947913 |
| | Interplay between the miRNome and the epigenetic machinery: Implications in health and disease. | Q39098623 |
| | μ opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes | Q39363573 |
| | Serum levels of BDNF are associated with craving in opiate-dependent patients. | Q39479692 |
| | DNA methylation has a local effect on transcription and histone acetylation | Q39675456 |
| | Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). | Q39779618 |
| | Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. | Q40168982 |
| | The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study | Q40171406 |
| | Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users | Q41633643 |
| | Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens | Q42393444 |
| | The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. | Q42917548 |
| | Lifetime multiple substance use pattern among heroin users before entering methadone maintenance treatment clinic in Yunnan, China | Q42968271 |
| | Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia | Q43213071 |
| | Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. | Q43281713 |
| | The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study | Q43695146 |
| | A national study of the retention of Irish opiate users in methadone substitution treatment | Q43706695 |
| | Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis | Q43884128 |
| P577 | publication date | 2017-08-25 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives | |